-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QkL3iRWYMQjg9DkWO+2tJDt2WRbgMg6VK8dgr6J5aIUxQ6n6umklYsGTra8YkVil RENXm8QZSYk7oldTtTDdCA== 0000912057-96-010137.txt : 19960518 0000912057-96-010137.hdr.sgml : 19960518 ACCESSION NUMBER: 0000912057-96-010137 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960408 FILED AS OF DATE: 19960516 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 96568503 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY SUITE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 10-C 1 10-C SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------------- FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM Filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder NPS PHARMACEUTICALS, INC. --------------------------------------------- (Exact name of issuer as specified in charter) Delaware 0-23272 87-0439579 - ---------------------------- ------------------------ ------------------- (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No.) 420 Chipeta Way Salt Lake City, Utah 84108-1256 -------------------------------------- (Address of principal executive offices, including zip code) (801) 583-4939 ------------------------ (Issuer's telephone number, including area code) ITEM I. CHANGE IN NUMBER OF SHARES OUTSTANDING 1. Title of security: Common Stock ------------------------------------------------------ 2. Number of Shares outstanding before the change: 8,187,232 ------------------------ 3. Number of Shares outstanding after the change: 11,637,232 ------------------------ 4. Effective date of change: May 8, 1996 ----------------------------------------------- 5. Method of change: Sale to Underwriters and Underwriters' exercise of over- -------------------------------------------------------- allotment option and public offering covered by Registration Statement on --------------------------------------------------------------------------- Form S-1 (File No. 333-02566). --------------------------------------------------------------------------- Dated: May 14, 1996 NPS PHARMACEUTICALS, INC. By: /s/ Robert K. Merrell ------------------------------ Robert K. Merrell Vice President, Finance, Chief Financial Officer and Treasurer -----END PRIVACY-ENHANCED MESSAGE-----